Xu ZJ - Search Results

1

Comprehensive characterization of TGFB1 across hematological malignancies.

Wang CZ, Zhang ZQ, Zhang Y, Zheng LF, Liu Y, Yan AT, Zhang YC, Chang QH, Sha S, Xu ZJ. Wang CZ, et al. Among authors: xu zj. Sci Rep. 2023 Nov 4;13(1):19107. doi: 10.1038/s41598-023-46552-8. Sci Rep. 2023. PMID: 37925591 Free PMC article.

2

The M2 macrophage marker CD206: a novel prognostic indicator for acute myeloid leukemia.

Xu ZJ, Gu Y, Wang CZ, Jin Y, Wen XM, Ma JC, Tang LJ, Mao ZW, Qian J, Lin J. Xu ZJ, et al. Oncoimmunology. 2019 Nov 3;9(1):1683347. doi: 10.1080/2162402X.2019.1683347. eCollection 2020. Oncoimmunology. 2019. PMID: 32002295 Free PMC article.

3

Methylation-independent CRIP1 expression is a potential biomarker affecting prognosis in cytogenetically normal acute myeloid leukemia.

Ma BB, Zhang TJ, Wang CZ, Xu ZJ, Zhou JD, Gu Y, Ma JC, Deng ZQ, Lin J, Qian J. Ma BB, et al. Among authors: xu zj. Am J Transl Res. 2020 Sep 15;12(9):4840-4852. eCollection 2020. Am J Transl Res. 2020. PMID: 33042393 Free PMC article. Review.

4

Pan-cancer analysis identifies ITIH1 as a novel prognostic indicator for hepatocellular carcinoma.

Chang QH, Mao T, Tao Y, Dong T, Tang XX, Ge GH, Xu ZJ. Chang QH, et al. Among authors: xu zj. Aging (Albany NY). 2021 Mar 21;13(8):11096-11119. doi: 10.18632/aging.202765. Epub 2021 Mar 21. Aging (Albany NY). 2021. PMID: 33744857 Free PMC article.

5

Reduced expression of lncRNA DLEU7-AS1 is a novel favorable prognostic factor in acute myeloid leukemia.

Wang CZ, Ma BB, Xu ZJ, Zhou JD, Zhang TJ, Chen Q, Yao DM, Lin J, Qian J, Sha S. Wang CZ, et al. Among authors: xu zj. Biosci Rep. 2022 May 27;42(5):BSR20212078. doi: 10.1042/BSR20212078. Biosci Rep. 2022. PMID: 35506368 Free PMC article.

6

m6A regulator-based methylation modification patterns and characterization of tumor microenvironment in acute myeloid leukemia.

Xu ZJ, Wen XM, Zhang YC, Jin Y, Ma JC, Gu Y, Chen XY, Xia PH, Qian W, Lin J, Qian J. Xu ZJ, et al. Front Genet. 2022 Aug 10;13:948079. doi: 10.3389/fgene.2022.948079. eCollection 2022. Front Genet. 2022. PMID: 36035161 Free PMC article.

7

A novel methionine metabolism-related signature predicts prognosis and immunotherapy response in lung adenocarcinoma.

Chang QH, Zhang YC, Zhang DY, Mao T, Chang R, Wang N, Ye Y, Xu ZJ. Chang QH, et al. Among authors: xu zj. Aging (Albany NY). 2023 May 2;15(9):3498-3523. doi: 10.18632/aging.204687. Epub 2023 May 2. Aging (Albany NY). 2023. PMID: 37179124 Free PMC article.

8

Pan-cancer analysis identifies CD300 molecules as potential immune regulators and promising therapeutic targets in acute myeloid leukemia.

Xu ZJ, Jin Y, Zhang XL, Xia PH, Wen XM, Ma JC, Lin J, Qian J. Xu ZJ, et al. Cancer Med. 2023 Jan;12(1):789-807. doi: 10.1002/cam4.4905. Epub 2022 May 31. Cancer Med. 2023. PMID: 35642341 Free PMC article.

9

The validation and clinical significance of LPCAT1 down-regulation in acute myeloid leukemia.

Chen Q, Xu Z, Lin J, Deng Z, Qian J, Qian W. Chen Q, et al. Mol Biol Rep. 2023 Jun;50(6):4955-4963. doi: 10.1007/s11033-023-08449-7. Epub 2023 Apr 20. Mol Biol Rep. 2023. PMID: 37079124

10

H19 overexpression promotes leukemogenesis and predicts unfavorable prognosis in acute myeloid leukemia.

Zhang TJ, Zhou JD, Zhang W, Lin J, Ma JC, Wen XM, Yuan Q, Li XX, Xu ZJ, Qian J. Zhang TJ, et al. Among authors: xu zj. Clin Epigenetics. 2018 Apr 10;10:47. doi: 10.1186/s13148-018-0486-z. eCollection 2018. Clin Epigenetics. 2018. PMID: 29643943 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

636 results

Search Page

Filters